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NF-jB–dependent increase in intrarenal angiotensin II induced
by proteinuria.
Background. Intrarenal activation of the renin-angiotensin
system has been suggested to play a pivotal role in the progres-
sion of various renal diseases, but the regulation of each com-
ponent has not been fully clarified. We investigated the roles of
nuclear factor jB (NF-jB) activation in the intrarenal renin-
angiotensin system changes induced by proteinuria.
Methods. We used unilaterally nephrectomized rats loaded
with bovine serum albumin as a model of proteinuric renal in-
jury. Renal NF-jB activation was inhibited by gene transfer of
the truncated form of IjBa via injection of a recombinant ade-
novirus vector into the renal artery, as we reported previously.
Results. Inhibition of renal NF-jB activation attenuated the
increases in intrarenal angiotensinogen protein (2.0-fold in rats
with protein overloading and saline injection to 1.3-fold in rats
with protein overloading and injection of a truncated form
of IjBa) and angiotensin II (1.8-fold to 1.2-fold), and an-
giotensinogen mRNA. The increases in angiotensin-converting
enzyme (ACE) and angiotensin II receptor type 2 were unaf-
fected by NF-jB inhibition. The expression of ACE2, an en-
zyme that metabolizes angiotensins I and II, was decreased by
37%, and NF-jB inhibition abolished the decrease. Immuno-
histochemical analysis revealed that the angiotensinogen and
ACE2 expression changes occurred mainly in proximal tubule
cells (i.e., the target of adenoviral gene transfer).
Conclusion. These results indicate that proteinuria induces
an increase in renal angiotensin II in an NF-jB–dependent
manner. Induction of angiotensinogen and decrease in ACE2
levels may be involved in this NF-jB–dependent increase in
angiotensin II.
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Essential components of the renin-angiotensin system
(RAS) are present in the kidney, and it has been suggested
that intrarenal angiotensin (Ang) II levels are regulated
by factors unique to the intrarenal microenvironment,
irrespective of circulating Ang II concentrations [1]. Ac-
cumulating evidence suggests that inhibition of intrarenal
activation of RAS may be particularly important to slow-
ing the progression of the chronic renal injury associated
with hypertension, diabetes, and persistent proteinuria
[1–7]. The mechanism by which intrarenal Ang II levels
are elevated during the course of the renal injury has not,
however, been thoroughly investigated.
In addition to indicating the presence of glomeru-
lar injury, persistent proteinuria itself is thought to
induce tubulointerstitial injury by stimulating renal tubu-
lar cells to produce proinflammatory cytokines [8, 9]. In
addition, the angiotensin-converting enzyme (ACE), an-
giotensinogen, and angiotensin II type 2 (AT2) receptors
have been demonstrated to be induced in the kidney by
persistent proteinuria [3, 10].
In a previous study, we showed that adenoviral delivery
of IjBN, a truncated form of IjBa, specifically inhibited
activation of nuclear factor-jB (NF-jB) and abolished
vascular cellular adhesion molecule-1 (VCAM-1) induc-
tion in renal proximal tubules with protein overload–
induced proteinuria [11]. Consequently, this adenoviral
gene transfer mitigated the tubulointerstitial injury in-
duced by protein-overload proteinuria [11]. Because the
expression of angiotensinogen in hepatocytes, which are
thought to be the source of circulating angiotensinogen,
has been shown to be regulated by NF-jB [12, 13], we
used adenoviral delivery of IjBN in the present study to
clarify the roles of NF-jB in the intrarenal RAS changes
induced by proteinuria.
In order to observe the effects of proteinuria in the
early stage of the injury, we performed the analyses 1
week after the start of protein overload, when acute
changes characterized by mild expansion of the
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interstitial space due to increased monocytes/
macrophages and edema are observed [14]. In ad-
dition to investigating classic RAS components, we also
investigated ACE2 expression, a recently discovered en-
zyme that is thought to counteract ACE by hydrolyzing
Ang I to Ang (1–9) and Ang II to Ang (1–7) [1].
METHODS
Animals and experimental design
Recombinant adenovirus expressing the nondegraded
form of the NF-jB inhibitor IjBa (AdexIjBN) [11,
15] and recombinant lacZ adenovirus (AdexlacZ; kindly
provided by Dr. I. Saito, Tokyo University, Tokyo, Japan)
[16] containing the gene encoding Escherichia coli b-
galactosidase were used for the gene transfer.
One week after uninephrectomy of 6-week-old female
Wistar rats, 1 mL of saline, AdexlacZ (1.0 × 108 PFU/mL)
dissolved in 1 mL of saline, or AdexIjB (1.0 × 108
PFU/mL) dissolved in 1 mL of saline was injected into
the renal artery of the remaining kidney. One week later,
daily intraperitoneal injections of 2 g bovine serum al-
bumin (BSA; Sigma Chemical Company, St. Louis, MO)
or saline for 7 days was started in the animals that had
received a saline or an adenovirus injection into the re-
nal artery. The animals receiving a saline injection into
the renal artery followed by intraperitoneal saline or
BSA injections were designated the control and BSA-
saline groups, respectively. The animals receiving either
an AdexlacZ or an AdexIjBN injection into the re-
nal artery followed by intraperitoneal BSA injections
were designated the BSA-lacZ and BSA-IjBN groups,
respectively. To measure 24-hour urinary protein excre-
tion and 24-hour creatinine clearance, the animals were
placed in individual metabolic cages for urine collection.
After the rats had been euthanized at the end of the
7-day course of BSA loading, the remaining kidney was
perfused with cold saline and removed. Small pieces of
cortex were immediately placed in liquid nitrogen for
measurement of Ang II, Western blot analysis, and re-
verse transcription-polymerase chain reaction (RT-PCR)
studies. Samples for measurement of NF-jB activity and
histologic studies were processed according to methods
described in our previous report [11].
Blood was collected at the time of sacrifice to deter-
mine serum albumin, creatinine, and Ang II levels. Blood
pressure was measured by tail-cuff plethysmography be-
fore sacrifice.
Quantification of Ang II levels
Ang II concentrations were measured as described pre-
viously [17, 18]. In brief, the cortical tissue was homoge-
nized and extracted in a cold buffer containing 0.1 mol/L
tris(hydroxymethyl)aminomethane HCl, pH 7.4, a pro-
tease inhibitor cocktail (Complete, Roche Diagnostics
GmbH, Penzberg, Germany), and 3.5 mmol/L EDTA.
The tissue extracts and blood samples were then partially
purified by ethanol extraction. Quantification of Ang
II was performed by a competitive protein-binding ra-
dioimmunoassay, as described previously [19]. The cross-
reactivities of angiotensins I and III against the antibody
(Mitsubishi BCL Co., Tokyo, Japan) used for the assay
were 0.3% and 8.2%, respectively.
Western blot and immunohistochemical analyses
Protein levels and localization of the renal RAS were
determined by Western blot and immunohistochemical
analyses according to previously described methods [3,
11]. After determination of the protein concentration
with a protein assay kit (Bio-Rad, Richmond, CA, USA),
equal amounts of protein (40 lg) were subjected to
sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis (SDS-PAGE). Densitometric analysis was performed
with the NIH image program.
Goat polyclonal antibodies to ACE, ACE2, and AT1
and AT2 receptors (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA, USA) were diluted 1:200 for Western blot
analysis. Sheep polyclonal antibody against rat an-
giotensinogen was generously provided by Dr. C. Sernia
(University of Queensland, Australia) [20], and diluted
1:4000 for Western blot analysis and 1:5000 for immuno-
histochemical analysis. Rabbit polyclonal antibody to
ACE and goat polyclonal antibody to ACE2 (Santa Cruz
Biotechnology, Inc.) were used for immunohistochemical
analyses at a dilution of 1:200. Goat polyclonal antibody
to megalin (Santa Cruz Biotechnology, Inc.), a marker
protein of proximal tubule epithelial cells [21], was used
for immunohistochemical analysis to identify proximal
tubules at a dilution of 1:50. Alexa Fluor 546 goat anti-
sheep immunoglobulin G (IgG) and Alexa Fluor 488 don-
key antigoat IgG (Molecular Probes, Inc., Eugene, OR,
USA) were used at a dilution of 1:200 as secondary anti-
bodies for the detection of angiotensinogen and megalin,
respectively. For the immunohistochemical detection of
ACE and ACE2, immobilized antibody was detected
using a TSA Fluorescence Systems kit (Perkin-Elmer,
Boston, MA, USA), and fluorescein as the fluorophore,
according to the manufacturer’s instructions. After stain-
ing of nuclei with TO-PRO-3 (Molecular Probes, Inc.),
sections were analyzed by confocal laser-scanning mi-
croscopy (Leica DMIR/E2 TCS SL; Leica GmbH,
Wetzlar, Germany).
Electrophoretic mobility shift assay and densitometry
Electrophoretic mobility shift assay for NF-jB in
the renal cortex was performed as described previously
[11]. The density of the specific NF-jB complex, which
can be abolished by an excess of unlabeled consensus
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oligonucleotides, but not by mutant oligonucleotides, was
determined with a laser scanning densitometer and image
analysis software (BAStation Fuji Photo Film Co., Ltd.,
Kanagawa, Japan) [11]. Values obtained by densitomet-
ric analysis of the NF-jB complex were normalized and
expressed as percentages of the control.
RT-PCR analysis
Total RNA was extracted from the renal cortex with
an RNA extraction kit, RNeasy Mini (Qiagen Sciences,
Hilden, Germany). The cDNA product was synthesized
and amplified by PCR with a commercial kit (Titanium
One-Step RT-PCR Kit; Clontech Laboratories, Inc., Palo
Alto, CA, USA). The sequences of primers were as fol-
lows: angiotensinogen: sense, 5′-TTGTTGAGAGCTT
GGGTCCCTTCA -3′; antisense, 5′-CAGACACTGA
GGTGCTGTTGTCCA-3′, yielding a 264 bp fragment
[22]; renin: sense, 5′-CGGTGGTCCTCACCAACT-3′;
antisense, 5′-GCCCATGCCCAGACCCCC-3′, yielding
a 368 bp fragment [3]; and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH): 5′-TCCCTCAAGATTGT
CAGCAA -3′; antisense, 5′-AGATCCACAACGGAT
ACATT -3′, yielding a 308 bp fragment [23]. PCR was
initiated by 5-minute incubation at 94◦C, followed by
30 cycles of 1 minute at 94◦C, 1 minute at 66◦C for an-
giotensinogen and GAPDH, and 60◦C for renin, and 1
minute at 72◦C. The linear range of PCR cycles was first
determined for each gene, and all subsequent RT-PCR ex-
periments were carried out using the cycle number within
the exponential phase. The resulting reaction products
were analyzed by gel electrophoresis (2% agarose).
Statistics
All data are expressed as mean ± SEM. Multiple
parametric comparisons were evaluated by analysis of
variance, followed by Fisher protected least significant
difference test. P values of less than 0.05 were consid-
ered statistically significant.
RESULTS
Effect of AdexIjB∆N on development of nephropathy
with protein overloading
In contrast to 3 weeks of BSA loading [11], 1 week of
BSA loading induced only mild histologic changes [14].
As shown in Figure 1B and C, mild expansion of the in-
terstitial space due to an increase in inflammatory cells
and edema was observed, as compared to the control
(Fig. 1A). There were no remarkable tubular changes at
this time point (Fig. 1B and C). However, a significant in-
crease in NF-jB activation was already apparent at this
stage, as we reported previously [11] (Fig. 1E). These
results indicate that this time window may be appro-
priate for evaluating changes in early proinflammatory
molecules possibly involved in the subsequent tubuloint-
erstitial injury. As we reported previously [11], treatment
with Adex(jBN reduced the mild interstitial expansion
and NF-jB activation (Fig. 1D and E).
As shown in Table 1, urinary protein excretion in-
creased significantly after the start of intraperitoneal
BSA overloading, but did not differ significantly among
the BSA-saline, BSA-lacZ, and BSA-IjBN groups dur-
ing the course of BSA loading. The kidney-to-body
weight ratio was significantly higher in the BSA-loaded
rats than in the control group, probably reflecting the mild
interstitial changes. This ratio in the BSA- IjBN group
was, however, significantly lower than that in the BSA-
saline and BSA-lacZ groups. The serum albumin levels
of the BSA-loaded groups were significantly higher than
those of the control group, regardless of whether they had
been injected with AdexlacZ or AdexIjBN. The serum
creatinine level, 24-hour creatinine clearance, and blood
pressure did not differ significantly at sacrifice according
to whether the animals had been protein overloaded.
Inhibition of the increase in renal Ang II by AdexIjB∆N
As shown in Figure 2, cortical concentrations of Ang
II were significantly increased by protein overloading in
the BSA-saline and BSA-lacZ groups, but the increase
was markedly attenuated in the BSA-IjBN group. By
contrast, the serum Ang II concentration was signifi-
cantly lower in the BSA-loaded groups than in the control
group, but did not differ among the BSA-loaded groups.
Effect of AdexIjB∆N on changes in renal
angiotensinogen, ACE, ACE2, and AT1 and AT2
receptor levels
Since the intrarenal Ang II concentration changes de-
pended on NF-jB activation, we analyzed the protein
levels of other components of the RAS by Western blot
analysis. As shown in Figure 3, after 1 week of pro-
tein overloading, angiotensinogen protein, a band with
a molecular size of 52 kD [24], was induced in the renal
cortex, but the induction of intrarenal angiotensinogen
was prevented by AdexIjBN. The expressions of ACE
and the AT2 receptor in the renal cortex were increased
by protein overloading, but there were no differences
among the BSA-loaded groups. By contrast, expression
of ACE2 in the renal cortex was decreased in the BSA-
saline and BSA-lacZ groups, while this ACE2 protein de-
crease was prevented by AdexIjBN treatment. There
were no changes in AT1 receptor levels.
Immunohistochemical analysis of angiotensinogen,
ACE, and ACE2
An immunohistochemical analysis was performed to
determine where the changes in protein expression oc-
curred in renal tissue (Fig. 4). Angiotensinogen was
mainly localized in proximal tubule epithelial cells in
the control group (Fig. 4A to C). After BSA loading,
Takase and Marumo et al: NF-jB regulates renal angiotensin II 467
200
150
100
50
0N
F-
κ
B 
de
ns
ito
m
et
ry
,
 
%
 o
f c
on
tro
l
Control BSA-
saline
BSA-
lacZ
BSA-
lκB∆N
E
*
*
#
**
Fig. 1. Representative photomicrographs of
periodic acid–Schiff staining of kidney sec-
tions from the control (A), bovine serum al-
bumin (BSA)-saline (B), BSA-lacZ (C), and
BSA-IjB∆N (D) groups (original magnifica-
tion ×200), and densitometric analysis of the
autoradiographic results of electrophoretic
mobility shift assay for NF-jB in nuclear ex-
tracts from the renal cortex (E). The control
group received a saline injection into the renal
artery and daily intraperitoneal saline injec-
tions. The BSA-saline group received a saline
injection into the renal artery and daily in-
traperitoneal BSA injections. The BSA-lacZ
group received a recombinant lacZ aden-
ovirus injection into the renal artery and daily
BSA injections. BSA-IjBN group received
a recombinant IjBN adenovirus injection
into the renal artery and daily BSA injections.
The data shown in panel E are mean ± SEM
(4 animals in each group). ∗P < 0.05 vs. con-
trol group; #P < 0.05 vs. BSA-saline group;
∗∗P < 0.05 vs. BSA-lacZ group.
a marked increase in angiotensinogen expression was
observed in proximal tubules (Fig. 4D to F). In addi-
tion to proximal tubules, some glomerular cells (Fig. 4J,
red signals in the glomerulus), and a few tubules nega-
tive for megalin (Fig. 4F, arrowhead) were also stained
for angiotensinogen, although at a much lower intensity
than in activated proximal tubules. In the BSA-IjBN
group, induction of angiotensinogen was attenuated, and
its expression was essentially confined to the proximal
tubules (Fig. 4G to I). Consistent with a previous re-
port [3], the ACE expression was increased by BSA
loading mainly in the proximal tubules, but some other
tubules and glomerular cells were also positive for ACE
(Fig. 5A to C). In contrast to angiotensinogen, neither
the intensity nor the distribution of ACE was altered
in the BSA-IjBN group (Fig. 5D) compared to the
BSA-lacZ group. In the BSA-lacZ group, tubules with
strong positive staining for angiotensinogen were mostly
ACE positive, but some tubules positive for only one
of the two were also identified (Fig. 4J to L). ACE2
was expressed predominantly in renal tubules, including
megalin-positive tubules (Fig. 5E and F), while only occa-
sional and weak staining was observed in glomerular cells.
The ACE2 intensity in renal tubules was decreased in the
BSA-lacZ group, while ACE2 expression was maintained
in the BSA-IjBN group (Fig. 5G and H). No significant
staining was observed in the absence of the primary an-
tibodies (data not shown).
Effect of AdexIjB∆N on changes in mRNA levels
of angiotensinogen and renin
To investigate whether the changes in angiotensino-
gen protein levels were accompanied by alterations in
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Table 1. Biochemical profiles of the 4 groups
Control BSA-saline BSA-lacZ BSA-IjBN
Urinary protein day 3 mg/day 1.3 ± 0.5 227.2 ± 49.1a 175.4 ± 33.9a 199.9 ± 44.2a
Urinary protein day 7 mg/day 1.1 ± 0.3 208.0 ± 44.8a 216.1 ± 38.9a 184.9 ± 44.1a
Body weight g 202 ± 7.9 200 ± 5.2 197 ± 4.2 200 ± 6.8
Kidney/body weight ratio 0.67 ± 0.037 1.05 ± 0.036a 1.00 ± 0.043a 0.89 ± 0.034a,b
Serum albumin g/L 40.67 ± 0.80 51.33 ± 1.67a 52.50 ± 3.72a 52.00 ± 3.51a
Serum Cr lmol/L 34.18 ± 1.26 36.10 ± 2.86 30.94 ± 1.55 30.76 ± 1.62
24-hr CCr mL/min 0.44 ± 0.096 0.45 ± 0.084 0.45 ± 0.101 0.39 ± 0.024
Blood pressure mm Hg 125 ± 5.4 122 ± 9.7 138 ± 5.3 134 ± 4.6
The control group received a saline injection into the renal artery and daily intraperitoneal saline injections. The BSA-saline group received a saline injection into
the renal artery and daily intraperitoneal bovine serum albumin (BSA) injections. The BSA-lacZ group received a recombinant lacZ adenovirus injection into the
renal artery and daily BSA injections. The BSA-IjBN group received a recombinant IjBN adenovirus injection into the renal artery and daily BSA injections.
Biochemical data are represented as mean values ± SEM (6 to 7 animals in each group).
aP < 0.05 vs. control group; bP < 0.05 vs. BSA-saline group.
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Fig. 2. Angiotensin II levels in renal cortical tissue (A) and angiotensin
II concentrations in sera (B) from the control, BSA-saline, BSA-lacZ,
and BSA-IjB∆N groups. The data shown are mean ± SEM (4 animals
in each group). ∗P < 0.05 vs. control group; #P < 0.05 vs. BSA-saline
group; ∗∗P < 0.05 vs. BSA-lacZ group. Definitions of the groups are the
same as in Figure 1.
mRNA levels, RT-PCR analysis was performed. The an-
giotensinogen mRNA levels in renal cortical tissue were
up-regulated by protein overloading (Fig. 6), and the
induction of angiotensinogen mRNA was significantly
attenuated by AdexIjBN. The expression of renin
mRNA was decreased by protein overloading, but no dif-
ferences were observed among the BSA-loaded groups.
DISCUSSION
The results of this study demonstrate that protein-
uria elevates the intrarenal Ang II content in an NF-
jB–dependent manner. Because proteinuria-induced
elevations of angiotensinogen protein are inhibited by
AdexIjBN, the NF-jB–dependent pathway appears to
be involved in these changes induced by proteinuria. As
shown by megalin staining, the NF-jB–dependent in-
duction of angiotensinogen occurred mainly in proximal
tubule cells (i.e., the target of adenoviral gene transfer)
[11]. Indeed, NF-jB activation has been shown to oc-
cur mainly in proximal tubule cells in nephropathy with
protein overloading [25]. These observations suggest that
proteinuria-induced angiotensinogen expression may de-
pend on NF-jB activation in proximal tubule cells. This
conclusion is consistent with the results of in vitro stud-
ies demonstrating the essential role of NF-jB in the in-
duction of the angiotensinogen gene in hepatocytes [12,
13]. The results of the present study extend those find-
ings to the kidney, and suggest a potential role of this
pathway in the tubulointerstitial injury associated with
proteinuria, although a study using cultured renal cells
is required to clarify mechanism in detail. On the other
hand, the increased expression of ACE that was not in-
hibited by AdexIjBN appeared to contribute to the
increase in Ang II levels induced by proteinuria in an
NF-jB–independent manner. The observation that there
were tubules positive only for either angiotensinogen or
ACE after BSA loading may be explained by the dif-
ference in activation pathways for each protein, includ-
ing NF-jB dependency, as indicated herein. The tubules
strongly positive for angiotensinogen, however, were
mostly positive for ACE as well. This finding suggests
that protein overloading may activate these tubular cells
by stimulating multiple signaling pathways.
In addition to increased production of Ang II, protein-
uria may also alter Ang II degradation pathways. ACE2
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Fig. 3. Representative Western blot films for angiotensinogen, angiotensin-converting enzyme (ACE), ACE2, AT1 receptor (AT1 R), AT2 receptor
(AT2 R), and b-actin in the renal cortex of control, BSA-saline, BSA-lacZ, and BSA-IjB∆N rats (A). Values obtained by densitometric analysis of
Western blots for angiotensinogen (B), ACE (C), ACE2 (D), AT1 R (E), and AT2 R (F) were expressed relative to the control group values. The
data shown are mean ± SEM (4–6 animals in each group). ∗P < 0.05 vs. control group; #P < 0.05 vs. BSA-saline group; ∗∗P < 0.05 vs. BSA-lacZ
group. Definitions of the groups are the same as in Figure 1.
has been shown to be predominantly localized in the heart
and kidney, and appears to regulate the Ang II content
of these organs because local Ang II levels are elevated
in ACE2-deficient mice [26]. The ACE2 protein decrease
resulting from protein overloading in this study suggests
that suppression of ACE2-mediated degradation of Ang
I and Ang II contributes to the increase in intrarenal Ang
II induced by proteinuria, although the precise role of this
pathway needs to be clarified by a specific inhibitory ma-
neuver. Our observation that ACE2 is decreased in tubu-
lointerstitial injury caused by proteinuria is consistent
with the results of previous studies showing decreased re-
nal expression of ACE2 in rats with hypertension [26] and
diabetes [27], and supports the concept that decreased
ACE2 expression plays a role in intrarenal activation of
RAS. The finding that the decrease in tubular ACE2 is
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Fig. 4. Representative photomicrographs of immunostaining for an-
giotensinogen in kidney sections of the control, BSA-lacZ, and BSA-
IjB∆N groups. Sections of the kidney obtained from the control group
were stained for angiotensinogen (red) in (A), and megalin (green), a
marker of proximal tubules, in (B). Overlay images of double staining
for angiotensinogen and megalin are shown in (C). Tubule cells posi-
tive for angiotensinogen are also stained positive for megalin. Sections
of the kidney obtained from the BSA-lacZ group were stained for an-
giotensinogen (red) in (D), and megalin (green) in (E). Overlay images
of double staining for both are shown in (F). Proximal tubule cells stain-
ing strongly positive for angiotensinogen are indicated by arrows in (F).
Tubular cells positive for angiotensinogen, but negative for megalin, are
indicated by an arrowhead (F). Sections of the kidney obtained from
the BSA- IjBN group were stained for angiotensinogen (red) in (G),
and megalin (green) in (H). Overlay images of double staining for both
are shown in (I). Sections of the kidney obtained from the BSA-lacZ
group were stained for angiotensinogen (red) in (J), and ACE (green)
in (K). Overlay images of double staining for angiotensinogen and ACE
are shown in (L). Tubular cells positive for both angiotensinogen and
ACE are indicated by arrows, while an asterisk and an arrowhead indi-
cate a renal tubule positive mainly for either angiotensinogen or ACE,
respectively (L). The localization of glomeruli (gl) is indicated in panels
A, D, G, and J. Nuclei (blue) are stained with TO-PRO-3. Bars = 100
lm. Definitions of the groups are the same as in Figure 1.
inhibited by gene transfer of IjBN indicates that ACE2
is down-regulated by NF-jB activation in renal tubu-
lar cells in vivo. The precise mechanism by which NF-
jB modulates ACE2 expression, including alterations in
mRNA levels and post-transcriptional processing, awaits
further study. However, a signaling pathway(s) inhibiting
ACE2 expression may be triggered by NF-jB activation
in renal tubules exposed to proteinuria. In this regard,
NF-jB has recently been shown to inhibit several signal-
ing pathways, including those activated by TGF-b [28]
and JNK [29].
Fig. 5. Representative photomicrographs of immunostaining for
angiotensin-converting enzyme (ACE) and angiotensin-converting en-
zyme 2 (ACE2). Sections of the kidney obtained from the control (A),
BSA-lacZ (B), and BSA-IjBN (D) groups were stained for ACE
(red). To analyze the distribution of ACE protein, proximal tubules
were identified by staining the serial sections obtained from the BSA-
lacZ group for megalin (green) in (C). Asterisks in (B) correspond to
those in (C), indicating proximal tubules positive for ACE. Sections of
the kidney obtained from the control (E), BSA-lacZ (G), and BSA-
IjBN (H) groups were stained for ACE2 (red). Proximal tubules
were identified by staining the serial sections obtained from the control
group for megalin (green) in (F). Asterisks in (E) correspond to those
in (F), indicating proximal tubules positive for ACE2. The localization
of glomeruli (gl) is indicated. Nuclei (blue) are stained with TO-PRO-3.
Bars = 100 lm. Definitions of the groups are the same as in Figure 1.
Accumulation of Ang II from the circulation via an AT1
receptor–mediated process has been shown to raise the
intrarenal Ang II content in several experimental models
[5]. However, this mechanism does not appear to play a
major role in our model because serum Ang II levels
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Fig. 6. Reverse transcription-polymerase chain reaction (RT-PCR) of cortical mRNA for angiotensinogen and renin. RT-PCR was performed with
total RNA extracted from the renal cortices of control, BSA-saline, BSA-lacZ, and BSA-IjBN rats (A). Values obtained by densitometric analysis
of RT-PCR products for angiotensinogen (B) and renin (C) were normalized and expressed relative to the control group values. The data shown are
mean ± SEM (4 animals in each group). ∗P < 0.05 vs. control group; #P < 0.05 vs. BSA-saline group; ∗∗P < 0.05 vs. BSA-lacZ group. Definitions
of the groups are the same as in Figure 1.
decreased, and there was no increase in AT1 receptors in
renal tubules after protein overloading [3] (Fig. 3).
Absolute values of the intrarenal Ang II concentra-
tion published thus far vary considerably, even in the
normal rat kidney (65–450 fmol/g tissue) [5, 30, 31]. The
discrepancies may, in part, be due to differences in prepa-
ration, extraction, and assay methods. Possible degrada-
tion of angiotensinogen and/or angiotensins during the
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procedure may also affect the outcome. Although com-
parison of absolute values between studies is, thus, com-
plicated, the renal Ang II levels of control rats in the
present study (1400 fmol/g tissue) were higher than val-
ues reported previously [5, 30, 31]. We cannot rule out the
possibility that degradation of RAS components may not
have been completely prevented during the assay proce-
dure in our experiments. However, because uninephrec-
tomy has been shown to cause RAS activation in the re-
maining kidney [32, 33], the high renal angiotensin val-
ues observed in the present study may be at least partly
attributable to uninephrectomy, performed in all rats, in-
cluding those of the control group.
We observed decreases in serum Ang II levels after
BSA loading. Daily intraperitoneal injection of 2 g BSA
for 7 days is likely to cause marked increases in intravas-
cular volume. Acute volume loading with a solution con-
taining 1% BSA has been shown to lower plasma Ang II
concentrations to about one third of the normal level [34].
The mechanism by which BSA overloading decreased
serum Ang II in the present study remains unclear, but we
observed decreases in renal renin mRNA expression in
rats with protein overloading. This observation is consis-
tent with a report demonstrating decreased renin mRNA
expression in nephropathy with protein overloading [3].
Our results confirm their findings, and further indicate
that renin mRNA is down-regulated through an NF-jB–
independent pathway.
In contrast to a previous report showing that NF-jB
inhibitors reduced the degree of proteinuria caused by
glomerulonephritis [35], proteinuria was not ameliorated
by AdexIjBN in the present study. This finding sug-
gests that activation of tubular NF-jB does not play a
significant role in glomerular overfiltration of protein in
the present model of proteinuria. Indeed, the glomerular
changes observed in the present model are much milder
than the tubulointerstitial injury [11, 14]. Consistent with
the results of the present study, NF-jB inhibitors reduced
tubulointerstitial injury without changing the degree of
proteinuria in another model of proteinuric nephropathy
induced by adriamycin [36].
In a previous study, we obtained evidence that NF-jB
activation plays a role in the development of nephropa-
thy with protein overloading (i.e., administration of
AdexIjBN inhibited tubulointerstitial injury) [11]. The
present finding that intrarenal RAS had already been ac-
tivated at one week after the start of BSA overloading,
before marked tubulointerstitial injury became evident,
indicates RAS activation to be one of the earliest events
subsequent to NF-jB activation. Because previous re-
ports using different approaches showed RAS activation
to play an important role in the development of tubuloin-
terstitial injury after BSA loading [25, 37], inhibition of
RAS activation in the early stage of renal injury may be
involved in the beneficial effects of AdexIjBN.
An intrarenal positive RAS feedback mechanism has
recently been suggested by the discovery that administra-
tion of Ang II increases intrarenal Ang II levels [5, 24].
Because Ang II activates NF-jB in the kidney [4], the
NF-jB–dependent intrarenal RAS activation observed
in the present study may be involved in the putative pos-
itive feedback system.
CONCLUSION
The results of the present study indicate that increase
in the intrarenal Ang II induced by proteinuria depends
on NF-jB activation. Induction of angiotensinogen and
decreased expression of ACE2 may at least in part be
involved in this process. By inhibiting not only induction
of proinflammatory cytokines but also activation of in-
trarenal RAS, inhibition of renal NF-jB activation may
be therapeutically useful as a means of retarding the de-
velopment and progression of renal damage associated
with persistent proteinuria.
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